secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001104659-25-055992
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fennec shareholders approve all proposals at annual meeting, including director elections and equity plan amendment
--------------------------------------------------------------------------------

- All six director nominees elected; votes for each exceeded 13.2M versus under 1M withheld.
- Haskell & White LLP ratified as independent auditor with 19.67M votes for, 69k against.
- Advisory say-on-pay approved: 12.11M for, 1.60M against, 456k abstain.
- Amendment to 2020 Equity Incentive Plan approved: 12.93M for, 0.78M against, 459k abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925055992/0001104659-25-055992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925055992/tm2517069d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-055992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer